Home/Centessa Pharmaceuticals/Mario Alberto Accardi, PhD
MA

Mario Alberto Accardi, PhD

Chief Executive Officer and Director

Centessa Pharmaceuticals

Therapeutic Areas

Centessa Pharmaceuticals Pipeline

DrugIndicationPhase
ORX750Narcolepsy Type 1 (NT1)Phase 2
ORX142Neurological & Neurodegenerative DisordersPreclinical / Phase 1
ORX489Neuropsychiatric DisordersPreclinical
LockBody® PlatformOncologyDiscovery